Amylin Pharmaceuticals Newsletter sign up now
-
FDA Requests REMS, Final Label for Once-Weekly Diabetes Drug
... REMS, Final Label for Once-Weekly Diabetes Drug The FDA has asked Eli Lilly and Amylin Pharmaceuticals for final labeling information and a risk evaluation and mitigation strategy (REMS) before it ...
-
Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
... fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development ...
-
Amylin Pharmaceuticals (AMLN) Higher After FDA Responce
... Amylin Pharmaceuticals (AMLN) 3/15/10 PriceWatch Alert Support Down To $16.71 Posted: Monday, March 15, 2010 8:41 ...
-
Amylin Pharmaceuticals shares rise on FDA response for once - weekly diabetes drug
... NEW YORK (AP) - Shares of Amylin Pharmaceuticals jumped 13 percent Monday as the Food and Drug Administration asked for more information ...
-
Stocks Advancing Amid Heavy Short Interest - Amylin Pharmaceuticals Inc, Alkermes Inc, Cypress Bioscience Inc, Cell Therapeutics Inc
... with heavy short interest have begun to move. Companies included in today's scan are: Amylin Pharmaceuticals Inc (AMLN), Alkermes (ALKS), BankAtlantic Bancorp (BBX), XenoPort, Inc. (XNPT), Anchor BanCorp Wisconsin (ABCW), ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference (PRN)
, M.D., vice president, research and development strategic relations at The presentation will be webcast live through the "Investors" section of Amylin's corporate Web ...
-
Amylin Pharmaceuticals Finished At New High For Year Monday
...
-
Stocks Showing Unusually Heavy Volume - Shuffle Master Inc, Clear Channel Outdoor Holdings Inc, OceanFreight Inc, Amylin Pharmaceuticals Inc, Potash Corp. of Saskatchewan
...
-
Amylin Pharmaceuticals shares rise on FDA response for once-weekly diabetes drug
...
-
Amylin Pharmaceuticals shares rise on FDA response for once-
...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Response to BYDUREON complete response letter
... Medisorb® technology for long-acting medications. BYDUREON is not currently approved by any regulatory agencies. Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development ...
-
Shares of Amylin Up Over Diabetes Treatment
... Drug Discovery & Development - March 17, 2010 NEW YORK (AP) - Shares of Amylin Pharmaceuticals jumped 13 percent Monday as the Food and Drug Administration asked for more information ...
-
Amylin won't need further studies on drug
... approval yet Tuesday, March 16, 2010 at 12:02 a.m. A much-awaited diabetes drug from Amylin Pharmaceuticals has failed to win government approval, but the company escaped the worst-case scenario: a ...
-
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) ...
-
Amylin shares up on FDA response for diabetes drug
... drug The Associated Press | March 15, 2010 | 10:31 AM EDT Shares of Amylin Pharmaceuticals jumped 9 percent Monday as the Food and Drug Administration asked for more information ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
Presswire
Press Release Distribution Service
- Arizona Cuts Children's Health Insurance Program [19 Mar 2010]
News publications
- World News Report
- US Politics Today
- EU Politics Today
- Healthcare Industry Today
- Music Industry Today
- Agriculture Industry Today
- Energy Industry Today
- IT Industry Today
- Airline Industry Today
- Automotive Industry Today
- Finance Industry Today
© 2005-2010